Lupin

Lupin to sell entire stake in Japanese subsidiary Kyowa for over Rs3,702 cr

12 Nov 2019

Lupin founder-chairman Desh Bandhu Gupta dies at 79

27 Jun 2017

Gupta, who founded Lupin with Rs5,000 borrowed cash from his wife, turned it into a pharma giant with annual sales of Rs17,000-crore, and the eighth largest generic drug firm globally

Lupin gets US FDA nod for marketing generic Percocet tablets

28 Feb 2017

Lupin, BC Partners shortlisted for Bayer’s $1.1 bn dermatology business

14 Oct 2016

Lupin is mainly attracted by the Bayer dermatology business's regional presence in North America, where it is keen to expand

Lupin India’s most reputed drug brand; Sun, Cipla follow

18 Aug 2016

Lupin to buy 21 brands from Japan’s Shionogi for $150 mn

02 Aug 2016

Lupin told to sell two drugs for getting regulatory nod for Gavis acquisition

20 Feb 2016

Lupin buys US generics drug maker Gavis for $880 mn

23 Jul 2015

The cash-free and debt-free acquisition creates the fifth-largest portfolio of new drug filings with the US FDA, addressing a $63.8-billion market

USFDA approves Lupin’s plant and product, raises concern over process

23 Feb 2015

Govt hikes FDI limit in HDFC Bank, Lupin; opens $2.6 bn investment window

29 Jan 2015

3 Indian firms get FDA nod to sell generic hypertension drug

07 Jan 2015

Lupin ties up with Salix to sell US firm’s drugs in Canada

13 Sep 2014

Lupin in pact with Japan’s Yoshindo to set up joint venture `YL Biologics’

23 Apr 2014

Lupin recalls Suprax drug from US market after failing to meet US purity test

15 Apr 2014

Lupin to buy Mexican eye-treatments maker Laboratorios Grin

27 Mar 2014

Lupin acquires Dutch injectable company Nanomi BV

04 Feb 2014

Lupin, India's second-largest pharmaceutical company by market value, yesterday struck a deal to acquire Netherlands-based injectable company Nanomi BV

Pfizer files patent-infringement suits against Lupin, four others

06 Mar 2013

Lupin receives US FDA approval for generic diabetic drug

05 Jul 2012

Lupin Q4 net slightly up at Rs249 crore

10 May 2012

Lupin’s Q3 net rises nearly 5 per cent to Rs235 crore

24 Jan 2012

Lupin to acquire Japan’s I'rom Pharmaceutical

17 Nov 2011

Lupin, Sanofi-Aventis Philippines in strategic agreement

05 Sep 2011

Eli Lilly ties up with Lupin to push diabetes drug sales

29 Jul 2011

Jhunjhunwala reduces stake in Lupin

20 Jul 2011

Lupin promoters to sell domestic operations: unconfirmed reports

18 Jul 2011